• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Atherogenic nature of triglycerides, postprandial lipidemia, and triglyceride-rich remnant lipoproteins.

作者信息

Zilversmit D B

机构信息

Division of Nutritional Sciences, Cornell University, Ithaca, NY 14853.

出版信息

Clin Chem. 1995 Jan;41(1):153-8.

PMID:7813071
Abstract

In addition to low-density lipoproteins, plasma chylomicrons and very-low-density lipoproteins (VLDL) contribute to atherogenesis. When triglyceride-rich particles bind to arterial endothelium and to deendothelialized areas, locally present lipoprotein lipase initiates triglyceride hydrolysis and decreases the size of the adhering particles. Additional changes in composition are brought about by the exchange of lipids between chylomicron/VLDL remnants and the cholesteryl ester-rich low- and high-density lipoproteins. These exchanges are mediated by lipid transfer proteins in plasma. Animal studies with doubly labeled lipoproteins show that the size of lipoprotein particles determines their rate of entering the artery and contributes to the formation of lesions. This model supports epidemiologic studies that have identified plasma triglycerides as a risk factor for atherogenesis. The model for a causal role of pre- and postprandial triglyceride-rich lipoproteins in atherogenesis suggests that measuring them may improve the assessment of cardiovascular risk factors.

摘要

相似文献

1
Atherogenic nature of triglycerides, postprandial lipidemia, and triglyceride-rich remnant lipoproteins.
Clin Chem. 1995 Jan;41(1):153-8.
2
Postprandial enrichment of remnant lipoproteins with apoC-I in healthy normolipidemic men with early asymptomatic atherosclerosis.在患有早期无症状动脉粥样硬化的健康血脂正常男性中,餐后残余脂蛋白中载脂蛋白C-I的富集情况。
Arterioscler Thromb Vasc Biol. 2002 Sep 1;22(9):1470-4. doi: 10.1161/01.atv.0000029972.42487.42.
3
Detection, quantification, and characterization of potentially atherogenic triglyceride-rich remnant lipoproteins.富含甘油三酯的潜在致动脉粥样硬化残余脂蛋白的检测、定量及特性分析。
Arterioscler Thromb Vasc Biol. 1999 Oct;19(10):2474-86. doi: 10.1161/01.atv.19.10.2474.
4
Triglyceride-rich lipoproteins and atherosclerosis, from fast to feast.富含甘油三酯的脂蛋白与动脉粥样硬化:从禁食到饱食
Ann Med. 1993 Oct;25(5):431-5. doi: 10.3109/07853899309147307.
5
[Postprandial lipemia as an atherosclerotic risk factor and fat tolerance test].[餐后血脂异常作为动脉粥样硬化危险因素及脂肪耐量试验]
Nihon Rinsho. 1999 Dec;57(12):2668-72.
6
Induction of atherosclerosis by human chylomicron remnants: a hypothesis.人乳糜微粒残粒诱导动脉粥样硬化:一种假说。
J Atheroscler Thromb. 2003;10(3):132-9. doi: 10.5551/jat.10.132.
7
Echolucent carotid artery plaques are associated with elevated levels of fasting and postprandial triglyceride-rich lipoproteins.颈动脉无回声斑块与空腹及餐后富含甘油三酯脂蛋白水平升高有关。
Stroke. 1996 Dec;27(12):2166-72. doi: 10.1161/01.str.27.12.2166.
8
Atherogenic postprandial remnant lipoproteins; VLDL remnants as a causal factor in atherosclerosis.动脉粥样硬化性餐后残余脂蛋白;VLDL 残粒作为动脉粥样硬化的一个致病因素。
Clin Chim Acta. 2018 Mar;478:200-215. doi: 10.1016/j.cca.2017.12.039. Epub 2018 Jan 4.
9
Postprandial remnant-like lipoproteins in hypertriglyceridemia.高甘油三酯血症中的餐后残留样脂蛋白
J Clin Endocrinol Metab. 2001 Jul;86(7):3134-42. doi: 10.1210/jcem.86.7.7627.
10
Triglycerides and atherogenic lipoproteins: rationale for lipid management.甘油三酯与致动脉粥样硬化脂蛋白:脂质管理的基本原理
Am J Med. 1998 Jul 6;105(1A):58S-62S. doi: 10.1016/s0002-9343(98)00213-7.

引用本文的文献

1
Remnant cholesterol in obesity phenotypes: results from NHANES.肥胖表型中的残余胆固醇:来自美国国家健康与营养检查调查(NHANES)的结果。
Lipids Health Dis. 2025 Apr 9;24(1):134. doi: 10.1186/s12944-025-02550-5.
2
Angiopoietin-like Proteins and Lipoprotein Lipase: The Waltz Partners That Govern Triglyceride-Rich Lipoprotein Metabolism? Impact on Atherogenesis, Dietary Interventions, and Emerging Therapies.血管生成素样蛋白与脂蛋白脂肪酶:调控富含甘油三酯脂蛋白代谢的华尔兹舞伴?对动脉粥样硬化形成、饮食干预及新兴疗法的影响
J Clin Med. 2024 Sep 4;13(17):5229. doi: 10.3390/jcm13175229.
3
Monoclonal Antibody chP3R99 Reduces Subendothelial Retention of Atherogenic Lipoproteins in Insulin-Resistant Rats: Acute Treatment Versus Long-Term Protection as an Idiotypic Vaccine for Atherosclerosis.
单克隆抗体 chP3R99 减少胰岛素抵抗大鼠动脉粥样硬化病变中致动脉粥样脂蛋白的血管内膜下滞留:作为动脉粥样硬化免疫原的急性治疗与长期保护
J Am Heart Assoc. 2024 Jul 2;13(13):e032419. doi: 10.1161/JAHA.123.032419. Epub 2024 Jun 27.
4
The chylomicron saga: time to focus on postprandial metabolism.乳糜微粒传奇:是时候关注餐后代谢了。
Front Endocrinol (Lausanne). 2024 Jan 18;14:1322869. doi: 10.3389/fendo.2023.1322869. eCollection 2023.
5
Sugar and Dyslipidemia: A Double-Hit, Perfect Storm.糖与血脂异常:双重打击,完美风暴。
J Clin Med. 2023 Aug 31;12(17):5660. doi: 10.3390/jcm12175660.
6
Triglyceride-Rich Lipoprotein Metabolism: Key Regulators of Their Flux.富含甘油三酯的脂蛋白代谢:其通量的关键调节因子
J Clin Med. 2023 Jun 29;12(13):4399. doi: 10.3390/jcm12134399.
7
Cepharanthine action in preventing obesity and hyperlipidemia in rats on a high-fat high sucrose diet.千金藤素对高脂高糖饮食大鼠预防肥胖和高脂血症的作用。
Saudi Pharm J. 2022 Dec;30(12):1683-1690. doi: 10.1016/j.jsps.2022.09.013. Epub 2022 Sep 21.
8
Addressing dyslipidemic risk beyond LDL-cholesterol.解决 LDL 胆固醇以外的血脂异常风险。
J Clin Invest. 2022 Jan 4;132(1). doi: 10.1172/JCI148559.
9
Dietary-Induced Elevations of Triglyceride-Rich Lipoproteins Promote Atherosclerosis in the Low-Density Lipoprotein Receptor Knockout Syrian Golden Hamster.饮食诱导富含甘油三酯的脂蛋白升高促进低密度脂蛋白受体敲除叙利亚金仓鼠的动脉粥样硬化。
Front Cardiovasc Med. 2021 Nov 2;8:738060. doi: 10.3389/fcvm.2021.738060. eCollection 2021.
10
Potential of Phage Display Antibody Technology for Cardiovascular Disease Immunotherapy.噬菌体展示抗体技术在心血管疾病免疫治疗中的潜力。
J Cardiovasc Transl Res. 2022 Apr;15(2):360-380. doi: 10.1007/s12265-021-10169-x. Epub 2021 Aug 31.